News Release Details

ROCKVILLE, Md.--(BUSINESS WIRE)--Jul. 10, 2014-- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call at 5:00 pm (Eastern Time) on Thursday, August 7, 2014.

Company management will discuss the financial results for the second quarter of 2014, recent business developments, revenue guidance for the third quarter of 2014, and revenue and net income guidance for full year 2014.

This conference call can be accessed live by telephone or through Emergent’s website:

Pre-registering for the live call will expedite access and minimize hold times. You will be issued a passcode to bypass the operator and connect directly. To pre-register for the call, visit the following website: https://www.theconferencingservice.com/prereg/key.process?key=P39XHRA7N

A replay will be available from 10:00 pm (Eastern Time) on August 7, 2014 through August 15, 2014.

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about us may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

Source: Emergent BioSolutions Inc.

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Global Public Affairs and Corporate Responsibility
301-795-1847
SchmittT@ebsi.com